The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage development and gain regulatory approval....
The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage development and gain regulatory approval....
– Conditional approval based on positive results from the HERIZON-BTC-01 Phase 2b trial –
DUBLIN, July 1, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ)...
Financing to accelerate commercialization of flagship products, service business, and entrance into U.S. market
STOCKHOLM, June 30, 2025 /PRNewswire/ -- Epigenica AB, a pioneer in high-throughput...
MONTREAL, June 26, 2025 /CNW/ - Pendopharm®, a division of Pharmascience Inc., has entered into an exclusive distribution agreement with KalVista Pharmaceuticals, Inc. (NASDAQ:...
BOSTON, June 25, 2025 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting...
COPENHAGEN, Denmark, June 25, 2025 /PRNewswire/ -- Designed proteins are anticipated to have groundbreaking impact on a range of issues from treating disease to...
COPENHAGEN, Denmark, June 25, 2025 /PRNewswire/ -- Designed proteins are anticipated to have groundbreaking impact on a range of issues from treating disease to...
Latest Research Demonstrates Promising Improved Glucose Homeostasis by Reprogramming Alpha Cells
AUSTIN, Texas, June 24, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a...
Study is the first to explore the impact of genetic ancestry on tumor genomics in T-ALL
PHILADELPHIA and MEMPHIS, Tenn., June 24, 2025 /PRNewswire/ --...
BOSTON, June 24, 2025 /PRNewswire/ -- Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced the appointment of Murray...
Breakthrough Studies Demonstrate Stem Cell-Based Technologies as a Potential Alternative Treatment for Type 1 Diabetes
CHICAGO, June 20, 2025 /PRNewswire/ -- Findings from two studies...